NCT07221903 The Lateral, Anterior, Medial (LAM) Femoral Cutaneous Block: A Case Series Harborview Medical Center, Seattle, WA
| NCT ID | NCT07221903 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Washington |
| Condition | Regional Anesthesia |
| Study Type | OBSERVATIONAL |
| Enrollment | 10 participants |
| Start Date | 2025-10-22 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 10 participants in total. It began in 2025-10-22 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Skin donor sites in patients undergoing split-thickness skin grafting surgeries can be very painful postoperatively. This site is most often the anterolateral thigh, the pain at which location can traditionally be covered by a fascia iliaca nerve block, although that comes with the disadvantage of losing motor functions in the femoral nerve distribution. The LAM nerve block, which is relatively new, aims to provide analgesia in the distribution of the lateral and anterior femoral cutaneous nerves. In short, this nerve block would decrease the sensation of the anterolateral thigh area without affecting the motor function of the leg. Investigators aim to study the consistency and coverage size of sensation changes by mapping out the area after the block in each patient.
Eligibility Criteria
Inclusion Criteria: 1. 18 years or older 2. Scheduled surgery for STSG w/ donor site coming from thigh 3. Care team requests LAM nerve block 4. Anticipated postop pain in the cutaneous areas of anterior and lateral thigh Exclusion Criteria: 5. Inability to communicate sensation or motor changes in their body 6. Preexisting sensory or motor deficits in the femoral nerve distribution 7. Contraindication to the medication used or a peripheral nerve block, such as allergy to amide local anesthetics, severe liver dysfunction, injection site infection etc 8. Pregnancy 9. Prisoners 10. Non-English Speaking/reading 11. Surgeries with anticipated or actual duration of 6 hours or longer 12. TBSA 20% or greater 13. Severe distracting injuries/polytrauma (e.g., large or significant bone fractures)
Contact & Investigator
Dorothy Wang, MD, MHA
PRINCIPAL INVESTIGATOR
University of Washington
Frequently Asked Questions
Who can join the NCT07221903 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Regional Anesthesia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07221903 currently recruiting?
Yes, NCT07221903 is actively recruiting participants. Contact the research team at ajames1@uw.edu for enrollment information.
Where is the NCT07221903 trial being conducted?
This trial is being conducted at Seattle, United States.
Who is sponsoring the NCT07221903 clinical trial?
NCT07221903 is sponsored by University of Washington. The principal investigator is Dorothy Wang, MD, MHA at University of Washington. The trial plans to enroll 10 participants.